Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06874101 · ClinicalTrials.gov registry record · NA
Respiratory Oxygen Adherence Monitor for Chronic Obstructive Pulmonary Disease Patients
A NA study, sponsored by Barron Associates.
- Not yet
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT06874101: Clinical Trial NA study, sponsored by Barron Associates.
NCT06874101 is a NA study that has not yet begun recruiting, run by Barron Associates. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06874101, a NA study, has not yet begun recruiting, sponsored by Barron Associates.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to test a device called "ROAM" that is being developed to see how patients with chronic obstructive pulmonary disease (COPD) use oxygen therapy over a long period of time. This study will focus on evaluating the ROAM device, which will be attached to your oxygen source. The question that the study aims to answer is: will patients who receive daily adherence feedback from the ROAM have increased adherence to their prescribed long term oxygen therapy regimens? Researchers will compare the amount of time using oxygen and attitudes about oxygen therapy observed in a group that receives feedback from ROAM, and a control group that does not receive feedback. Participants will have their oxygen supplies fitted with the ROAM device and then use their oxygen as usual for the 5-week study duration. Participants in the study group will have access to information about their oxygen usage and pulse oximetry levels. All participants will attend two in-clinic sessions of about an hour each, and will complete questionnaires at the beginning and end of the study.
Primary Outcome
Adherence rates are computed as the participant's average daily actual treatment time divided by the prescribed daily treatment time.
Interventions
- DEVICE Sham Comparator
- DEVICE Activated ROAM System with User Feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-05-01 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What is known before NCT06874101 opens enrollment
NCT06874101 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Sham Comparator is the first listed.
NCT06874101 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06874101 about?
NCT06874101 is a clinical study titled "Respiratory Oxygen Adherence Monitor for Chronic Obstructive Pulmonary Disease Patients". The goal of this clinical trial is to test a device called "ROAM" that is being developed to see how patients with chronic obstructive pulmonary disease (COPD) use oxygen therapy over a long period of time. This study will focus on evaluating the ROAM device, which will be attached to your oxygen so...
What is the current status of trial NCT06874101?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-05-01. Estimated completion is 2026-04-30.
What interventions are being tested in trial NCT06874101?
The interventions under investigation include: Sham Comparator (DEVICE), Activated ROAM System with User Feedback (DEVICE).
Who is sponsoring clinical trial NCT06874101?
This trial is sponsored by Barron Associates, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06874101's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI